R3 CEV Plans to Raise $200m for Blockchain Trials
The big question is whether or not R3 CEV can raise enough capital in the first place, although various consortium members have inquired as to how much capital is needed. Nearly everyone in the world of Bitcoin and blockchain technology will have heard of R3 CEV by now, as the consortium is backed by a lot of major banks around the world. This outfit is now looking to raise $US200 million for a new round of blockchain trials, assuming the participating banks are willing to part with their money. The R3 CEV Hunt for $USD200m in Funding. Actively exploring the boundaries of blockchain....
Related News
American Stock Exchange Nasdaq is planning to increase the number of Bitcoin blockchain trials this year, the finance news network FT reported. According to the available reports, the New York group is hoping to initiate three-to-four trials within the next 12 months, a step that will improve the sluggish confirmation process on US securities markets to a wonderful extent. The decision meanwhile is speculated to be born out of a reason to stay ahead with NYSE which, just a few days back, launched the first exchange-calculated and distributed bitcoin index. But Nasdaq's Chief Executive Bob....
New York-based blockchain startup R3CEV is currently in negotiations to raise a Series A funding round, people familiar with the group's plans have told CoinDesk. The source, who couldn’t speak on the record due to the sensitivity of the topic, said that R3 had been given a $200m pre-valuation according to an independent report carried out by Ernst & Young as part of the consortium's contract with its members. The $200m figure relates to a valuation prior to any investment made by outside investors, which could significantly increase the group’s valuation. Asked about the reports, R3's....
Nasdaq-listed Marathon said it will use the funds to pay for recent hardware purchases from Bitmain and to expand its business.
Two doctors have recently devised a concept that makes clinical trial documents immutable using blockchain technology. A universal method of keeping clinical research untampered is an issue within the medical field. Often these trials can be manipulated, and the resulting treatment and medication can be over-exaggerated. A Peer-Reviewed Clinical Trial....
IBM’s previously announced work intersecting blockchain and AI is moving forward with the establishment of a new office in Germany. The announcement is part of a broader technology push initiated this week by IBM, which is investing $200m to fuel its internet of things (IoT) efforts. IBM is opening a new office in Munich to spearhead those initiatives, within which its blockchain work on connected devices is based. IBM, a founding member of the open-source Hyperledger project, emerged earlier this year as a strong advocate for the technology. It has since pursued a variety of projects....